Developing microchip-based devices to analyze prostate cancer markers in blood

Dr. Shana Kelley and her team at the University of Toronto are looking at a new class of devices that may one day enable non-invasive screening and early detection of prostate cancer. An approach relying on nanotechnology will be employed to produce very sensitive, accurate devices that will sense the presence of prostate cancer cells in the blood, and will analyze the aggressiveness of the disease by detecting molecules that can report on the type of tumour present. This approach may ultimately have wider application for cancer or infectious disease screening.

Watch video about Dr. Kelley's research project